Treatment of Diabetes: A Clinical Update on Insulin Trials

Mokdad, 2003, Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001, JAMA, 289, 76, 10.1001/jama.289.1.76 Centers for Disease Control and Prevention The Diabetes Control and Complications Trial Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group, 2005, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes, N Engl J Med, 353, 2643, 10.1056/NEJMoa052187 UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complication in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Knatterud, 1978, Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment, JAMA, 240, 37, 10.1001/jama.1978.03290010041020 Malmberg, 1997, Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus, BMJ, 314, 1512, 10.1136/bmj.314.7093.1512 Berman Center for Outcomes & Clinical Research Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405 American Diabetes Association, 2007, Standards of medical care in diabetes–2007, Diabetes Care, 30, S4, 10.2337/dc07-S004 American Association of Clinical Endocrinologists, 2002, Medical guidelines for the management of diabetes mellitus: The AACE system of intensive diabetes self-management-2002 update, Endocr Pract, 8, 40 Berman Center for Outcomes & Clinical Research Duckworth, 2006, Control of cardiovascular risk factors in the Veterans Affairs Diabetes Trial in advanced type 2 diabetes, Endocr Pract, 12, 85, 10.4158/EP.12.S1.85 Wright, 2002, Sulfonylurea inadequacy. Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57) [published correction appears in Diabetes Care. 2002;25:1268], Diabetes Care, 25, 330, 10.2337/diacare.25.2.330 Yki-Jarvinen, 2002, Combination therapy with insulin and oral agents: Optimizing glycemic control in patients with type 2 diabetes mellitus, Diabetes Metab Res Rev, 18, S77, 10.1002/dmrr.304 Turner, 1999, Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49), JAMA, 281, 2005, 10.1001/jama.281.21.2005 Riddle, 2003, The Treat-to-Target Trial. Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients, Diabetes Care, 26, 3080, 10.2337/diacare.26.11.3080 2006 Hermansen, 2006, A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes [published correction appears in Diabetes Care. 2007;30:1035], Diabetes Care, 29, 1269, 10.2337/dc05-1365 2005 Janka, 2005, Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes, Diabetes Care, 28, 254, 10.2337/diacare.28.2.254